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Pathophysiological aldosterone (aldo)/mineralocorticoid receptor signaling has a
major impact on the cardiovascular system, resulting in hypertension and vascular
remodeling. Mineralocorticoids induce endothelial dysfunction, decreasing
vasorelaxation in response to acetylcholine and increasing the response to
vasoconstrictors. Activation of the epidermal growth factor receptor (EGFR) is
thought to mediate the vascular effects of aldo, but this has yet to be demonstrated in
vivo. In this study, we analyzed the molecular and functional vascular consequences
of aldo-salt challenge in the waved 2 mouse, a genetic model with a partial loss of
EGFR tyrosine kinase activity. Deficient EGFR activity is associated with global
oxidative stress and endothelial dysfunction. A decrease in EGFR activity did not
affect the arterial wall remodeling process induced by aldo-salt. By contrast, normal
EGFR activity was required for the aldo-induced enhancement of phenylephrine- and
angiotensin II-mediated vasoconstriction. In conclusion, this in vivo study
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